3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2390 | Cevimeline hydrochloride hemihydrate | AChR | |
Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren's syndrome. | |||
T13421 | (-)-Cevimeline hydrochloride hemihydrate | (-)-SNI-2011,(-)-AF102B hydrochloride hemihydrate | ALK |
Cevimeline hydrochloride hemihydrate ((-)-SNI-2011), a novel muscarinic receptor agonist, is being explored as a potential treatment for xerostomia in Sjogren's syndrome, exhibiting an IC50 value indicative of its affini... | |||
T13460 | (+)-Cevimeline hydrochloride hemihydrate | (+)-AF102B hydrochloride hemihydrate,(+)-SNI-2011 | Others |
(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011), a potent muscarinic receptor agonist, stands as a promising therapeutic candidate for treating xerostomia in Sjogren's syndrome. This compound has demonstrated a b... |